Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
Nature Immunology|April 1, 2021
TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell primingGaëtan Barbet, Priyanka Nair-Gupta, Michael Schotsaert, et al.
Frontiers in Genetics|June 20, 2022
Longitudinal Study of DNA Methylation and Epigenetic Clocks Prior to and Following Test-Confirmed COVID-19 and mRNA VaccinationAlina P S Pang, Albert T Higgins-Chen, Florence Comite, et al.
The Journal of Experimental Medicine|April 21, 2021
IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralizationCaroline Lanz, Michael Schotsaert, Carsten Magnus, et al.
STAR Protocols|November 22, 2023
Protocol for establishing primary human lung organoid-derived air-liquid interface cultures from cryopreserved human lung tissueDiana Cadena Castaneda, Sonia Jangra, Marina Yurieva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvantGabriel Laghlali, Matthew J Wiest, Dilara Karadag, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvantGabriel Laghlali, Matthew J Wiest, Dilara Karadag, et al.
Journal of Virology|January 13, 2017
Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a AntibodiesSilvie Van den Hoecke, Katrin Ehrhardt, Annasaheb Kolpe, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Outburst of serotype 4 IPD after COVID-19 is driven by ST15063/GPSC162 lineage associated with high-risk behaviors and greater virulence linked to influenza H3N2 virus coinfection and cigarette smokeCovadonga Pérez-García, Joaquin Llorente, Maria Elena Aguirre Alastuey, et al.
NPJ Vaccines|June 29, 2023
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged miceSonia Jangra, Jeffrey J Landers, Gabriel Laghlali, et al.
Pageof 14